Department of Cell Biology and Anatomy, University of Calgary, Calgary, AB, Canada.
Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Sci Rep. 2022 Jun 8;12(1):9474. doi: 10.1038/s41598-022-13388-7.
Removal of particulate materials that would otherwise cumulate within the airspace and hinder the gas exchange is one of the central processes of maintaining lung homeostasis. While the importance of the particle uptake by alveolar macrophages and their expulsion via the airways mucociliary escalator is well established, very little is known about the alternative route for removing the particles via direct crossing the lung epithelium for transfer into the pulmonary lymph and bloodstream. This study dissected sequential mechanisms involved in nanoparticle transcytosis through the alveolar epithelial cell layer. By a combination of live cell, super resolution, and electron microscopy and RNA interference study, we have dissected temporal steps of nanoparticle transcytosis through alveolar epithelium. Our study revealed that caveolin is essential for the firm adhesion of the silica nanoparticle agglomerates to the apical membrane and their subsequent rapid internalization with the help of macropinocytic elements C-terminal-binding protein1 and Rabankyrin-5 but not dynamin. Actin, but not microtubules, played a major role in nanoparticle uptake and subsequent transportation. The compartments with nanoparticles were tethered to trans-Golgi network to be jointly transported along actin stress fibers across the cytoplasm, employing a myosin-dependent mechanism. The trans-Golgi nanoparticle transport machinery was positive to Rab6A, a marker linked to vesicle exocytosis. Exocytosis was primarily occurring at the basolateral plane of the alveolar epithelial cells. The high-proficiency novel caveolin and Rabankyrin-5 associated uptake and transcellular transport of nanoparticles across the AEC barrier supports its importance in clearance of amorphous silica and other types of non-inflammatory nanoparticles that are rapidly removed from the lungs following their inhalation.
清除原本会在肺泡内积聚并阻碍气体交换的颗粒物质是维持肺内环境稳定的核心过程之一。肺泡巨噬细胞摄取颗粒并通过气道黏液纤毛清除系统排出的作用已得到充分证实,但对于通过直接穿过肺上皮细胞将颗粒转移到肺淋巴和血液中清除颗粒的替代途径,我们知之甚少。本研究剖析了纳米颗粒穿过肺泡上皮细胞层的易位的连续机制。通过活细胞、超分辨率、电子显微镜和 RNA 干扰研究相结合,我们剖析了纳米颗粒穿过肺泡上皮细胞易位的时间步骤。我们的研究揭示了小窝蛋白对于硅纳米颗粒聚集体牢固附着于顶膜以及随后在大胞饮元件 C 端结合蛋白 1 和 Rabankyrin-5 的帮助下迅速内化是必不可少的,但不是 dynamin。肌动蛋白,但不是微管,在纳米颗粒摄取和随后的运输中起主要作用。含纳米颗粒的隔室与 Trans-Golgi 网络相连,通过肌球蛋白依赖性机制沿肌动蛋白应力纤维共同运输穿过细胞质。Trans-Golgi 纳米颗粒运输机制对 Rab6A 呈阳性,Rab6A 是与囊泡胞吐作用相关的标志物。胞吐作用主要发生在肺泡上皮细胞的基底外侧平面。高效的新型小窝蛋白和 Rabankyrin-5 相关的摄取和跨细胞转运纳米颗粒穿过 AEC 屏障,支持其在清除无定形二氧化硅和其他类型的非炎症性纳米颗粒中的重要作用,这些颗粒在吸入后很快从肺部清除。